Kenneth Song - 17 Nov 2023 Form 4 Insider Report for RayzeBio, Inc.

Role
President and Chief Executive, Director
Signature
/s/ Jeff Woodley, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
17 Nov 2023
Net transactions value
$0
Form type
4
Filing time
17 Nov 2023, 18:38:03 UTC
Previous filing
14 Sep 2023
Next filing
27 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYZB Stock Option (right to buy) Award $0 +480,000 $0.000000 480,000 17 Nov 2023 Common Stock 480,000 $22.72 By trust F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest in a series of 48 successive equal monthly installments over the four-year period measured from the date of grant.
F2 The Song Family Trust dated October 14, 2016, or the Song Trust. Dr. Song is a trustee of the Song Trust, and may be deemed to have voting and investment power over the shares held by the Song Trust.